These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38328838)

  • 1. INTRA-ARTERIAL CHEMOTHERAPY AS A CLINICAL OPTION FOR METASTATIC COLORECTAL CANCER: CONVERSION OF INOPERABLE LIVER METASTASES TO OPERABLE ILLUSTRATED WITH A CLINICAL CASE.
    Cherchenko K; Lukashenko A; Ostapenko Y; Patsko V; Vinohradova M; Valikhnovska K; Pamanska S
    Exp Oncol; 2024 Feb; 45(4):515-522. PubMed ID: 38328838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic artery infusion for unresectable colorectal cancer liver metastases: Palliation and conversion.
    Zaidi MY; Nussbaum DP; Hsu SD; Strickler JH; Uronis HE; Zani S; Allen PJ; Lidsky ME
    Surgery; 2023 Aug; 174(2):428-430. PubMed ID: 37183130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Place of hepatic intra-arterial chemotherapy in the treatment of colorectal liver metastases.
    Allard MA; Malka D
    J Visc Surg; 2014 Apr; 151 Suppl 1():S21-4. PubMed ID: 24636278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases.
    Guan M; Chen SC; Ying HY; Zhao L; Li XY; Zhou JF; Shao YJ; Yang XD; Lin Y; Ning XH; Bai CM
    Chin Med J (Engl); 2012 Oct; 125(20):3640-5. PubMed ID: 23075717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous delivery of venous 5-fluorouracil and arterial 5-fluorodeoxyuridine for hepatic metastases from colorectal cancer: feasibility and tolerance in a randomized phase II trial comparing flat versus chronomodulated infusion.
    Focan C; Levi F; Kreutz F; Focan-Henrard D; Lobelle JP; Adam R; Dallemagne B; Jehaes C; Markiewicz S; Weerts J; Bismuth H; Jasmin C; Misset JL
    Anticancer Drugs; 1999 Apr; 10(4):385-92. PubMed ID: 10378673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined treatment of inoperable liver metastases from colorectal cancer].
    Milandri C; Calzolari F; Giampalma E; Vagliasindi A; Bertagni A; Ridolfi L; Passardi A; Ridolfi R; Golfieri R; Verdecchia GM
    Tumori; 2003; 89(4 Suppl):112-4. PubMed ID: 12903565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic artery infusion therapy is effective for chemotherapy-resistant liver metastatic colorectal cancer.
    Goi T; Naruse T; Kimura Y; Fujimoto D; Morikawa M; Koneri K; Yamaguchi A
    World J Surg Oncol; 2015 Oct; 13():296. PubMed ID: 26452624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
    Seki H; Ozaki T; Shiina M
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.
    Kemeny N; Jarnagin W; Paty P; Gönen M; Schwartz L; Morse M; Leonard G; D'Angelica M; DeMatteo R; Blumgart L; Fong Y
    J Clin Oncol; 2005 Aug; 23(22):4888-96. PubMed ID: 16009951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination of hepatic arterial infusion therapy and FOLFOX for colorectal cancer with multiple unresectable liver metastases causing severe liver dysfunction].
    Suto T; Sato T; Mori N; Takano N; Ishiyama K; Sakurai N; Saito K; Iizawa H; Ikeda E
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):71-6. PubMed ID: 19151566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OncoSurge: a strategy for long-term survival in metastatic colorectal cancer.
    Alberts S; Poston G
    Colorectal Dis; 2003 Nov; 5 Suppl 3():20-8. PubMed ID: 23573557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
    Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV.
    Lévi FA; Boige V; Hebbar M; Smith D; Lepère C; Focan C; Karaboué A; Guimbaud R; Carvalho C; Tumolo S; Innominato P; Ajavon Y; Truant S; Castaing D; De Baere T; Kunstlinger F; Bouchahda M; Afshar M; Rougier P; Adam R; Ducreux M;
    Ann Oncol; 2016 Feb; 27(2):267-74. PubMed ID: 26578731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma.
    Kemeny NE; Melendez FD; Capanu M; Paty PB; Fong Y; Schwartz LH; Jarnagin WR; Patel D; D'Angelica M
    J Clin Oncol; 2009 Jul; 27(21):3465-71. PubMed ID: 19470932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases.
    Kingham TP; D'Angelica M; Kemeny NE
    J Surg Oncol; 2010 Dec; 102(8):988-95. PubMed ID: 21166003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic artery ligation or embolization and locoregional chemotherapy of liver metastases from colorectal cancer.
    Gerard A; Pector JC; Bleiberg H
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2351-4. PubMed ID: 3137873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group.
    Bond MJG; Bolhuis K; Loosveld OJL; de Groot JWB; Droogendijk H; Helgason HH; Hendriks MP; Klaase JM; Kazemier G; Liem MSL; Rijken AM; Verhoef C; de Wilt JHW; de Jong KP; Gerhards MF; van Amerongen MJ; Engelbrecht MRW; van Lienden KP; Molenaar IQ; de Valk B; Haberkorn BCM; Kerver ED; Erdkamp F; van Alphen RJ; Mathijssen-van Stein D; Komurcu A; Lopez-Yurda M; Swijnenburg RJ; Punt CJA;
    Lancet Oncol; 2023 Jul; 24(7):757-771. PubMed ID: 37329889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic Arterial Infusion Chemotherapy of 5-Fluorouracil for Patients with Unresectable Liver Metastases from Colorectal Cancer Refractory to Standard Systemic Chemotherapy: A Multicenter Retrospective Study.
    Sato Y; Inaba Y; Aramaki T; Sone M; Morita Y; Nishiofuku H; Tanaka T; Miyazaki M; Matsueda K; Arai Y
    Oncology; 2020; 98(5):267-272. PubMed ID: 32092755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and feasibility of initiating a hepatic artery infusion pump chemotherapy program for unresectable colorectal liver metastases: A multicenter, retrospective cohort study.
    Muaddi H; D'Angelica M; Wiseman JT; Dillhoff M; Latchana N; Roke R; Ko YJ; Carpizo D; Spencer K; Fields RC; Williams G; Aucejo F; Acevedo-Moreno LA; Billingsley KG; Walker BS; Mayo SC; Karanicolas PJ
    J Surg Oncol; 2021 Jan; 123(1):252-260. PubMed ID: 33095919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases.
    Swierz MJ; Storman D; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009498. PubMed ID: 32163181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.